Literature DB >> 22893040

When the average applies to no one: personalized decision making about potential benefits of lung cancer screening.

Peter B Bach1, Michael K Gould.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22893040     DOI： 10.7326/0003-4819-157-8-201210160-00524

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  33 in total

Review 1.  Lung cancer screening: past, present and future.

Authors:  James H Finigan; Jeffrey A Kern
Journal:  Clin Chest Med       Date:  2013-07-23       Impact factor: 2.878

2.  Improving selection criteria for lung cancer screening. The potential role of emphysema.

Authors:  Pablo Sanchez-Salcedo; David O Wilson; Juan P de-Torres; Joel L Weissfeld; Juan Berto; Arantzazu Campo; Ana B Alcaide; Jesús Pueyo; Gorka Bastarrika; Luis M Seijo; Maria J Pajares; Ruben Pio; Luis M Montuenga; Javier J Zulueta
Journal:  Am J Respir Crit Care Med       Date:  2015-04-15       Impact factor: 21.405

3.  Results of the national lung cancer screening trial: where are we now?

Authors:  Neel P Chudgar; Peter R Bucciarelli; Elizabeth M Jeffries; Nabil P Rizk; Bernard J Park; Prasad S Adusumilli; David R Jones
Journal:  Thorac Surg Clin       Date:  2015-02-02       Impact factor: 1.750

4.  Delivering high-quality and affordable care throughout the cancer care continuum.

Authors:  Ya-Chen Tina Shih; Patricia A Ganz; Denise Aberle; Amy Abernethy; Justin Bekelman; Otis Brawley; James S Goodwin; Jim C Hu; Deborah Schrag; Jennifer S Temel; Lowell Schnipper
Journal:  J Clin Oncol       Date:  2013-10-14       Impact factor: 44.544

5.  Implementation of new clinical programs in the VHA healthcare system: the importance of early collaboration between clinical leadership and research.

Authors:  R Ryanne Wu; Linda S Kinsinger; Dawn Provenzale; Heather A King; Patricia Akerly; Lottie K Barnes; Santanu K Datta; Janet M Grubber; Nicholas Katich; Rebecca B McNeil; Robert Monte; Nina R Sperber; David Atkins; George L Jackson
Journal:  J Gen Intern Med       Date:  2014-12       Impact factor: 5.128

6.  Measures of outcome in lung cancer screening: maximising the benefits.

Authors:  Robert Peter Young; Raewyn Janice Hopkins
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 7.  Multimorbidity and evidence generation.

Authors:  Carlos O Weiss; Ravi Varadhan; Milo A Puhan; Andrew Vickers; Karen Bandeen-Roche; Cynthia M Boyd; David M Kent
Journal:  J Gen Intern Med       Date:  2014-01-18       Impact factor: 5.128

8.  Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.

Authors:  Rafael Meza; Kevin ten Haaf; Chung Yin Kong; Ayca Erdogan; William C Black; Martin C Tammemagi; Sung Eun Choi; Jihyoun Jeon; Summer S Han; Vidit Munshi; Joost van Rosmalen; Paul Pinsky; Pamela M McMahon; Harry J de Koning; Eric J Feuer; William D Hazelton; Sylvia K Plevritis
Journal:  Cancer       Date:  2014-02-27       Impact factor: 6.860

9.  Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.

Authors:  Meredith S Shiels; Hormuzd A Katki; Allan Hildesheim; Ruth M Pfeiffer; Eric A Engels; Marcus Williams; Troy J Kemp; Neil E Caporaso; Ligia A Pinto; Anil K Chaturvedi
Journal:  J Natl Cancer Inst       Date:  2015-07-28       Impact factor: 13.506

10.  Targeting of low-dose CT screening according to the risk of lung-cancer death.

Authors:  Anil K Chaturvedi; Hormuzd A Katki; Stephanie A Kovalchik; Martin Tammemagi; Christine D Berg; Neil E Caporaso; Tom L Riley; Mary Korch; Gerard A Silvestri
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.